Recovery of gastric function after Helicobacter pylori eradication in subjects with body atrophic gastritis: Prospective 4-year study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 11, 2005, Pages 1661-1666

  Di Mario, Francesco ^a   Moussa, Ali M ^a   Dal Bò, Nadia ^b   Caruana, Pietro ^a   Pilotto, Alberto ^c   Cavallaro, Lucas G ^a   Cavestro, Giulia M ^a   Iori, Veronica ^a   Merli, Roberta ^a   Franzé, Angelo ^d   Rugge, Massimo ^e  

^a UNIVERSITY OF PARMA   (Italy)

^b Gastroenterology Unit   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d Gastroenterology and Endoscopy Unit   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

Author keywords

Eradication therapy; Helicobacter pylori related atrophic body gastritis; Serum pepsinogen I

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; PEPSINOGEN I; RABEPRAZOLE; TINIDAZOLE; ANTIINFECTIVE AGENT; PEPSINOGEN;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; BLOOD LEVEL; CLINICAL ARTICLE; CONVALESCENCE; DISEASE SEVERITY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEALING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; STOMACH BIOPSY; STOMACH FUNCTION; STOMACH MUCOSA; BLOOD; LONGITUDINAL STUDY; MICROBIOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; STOMACH; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; FEMALE; GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PEPSINOGEN A; PROSPECTIVE STUDIES; STOMACH; TIME FACTORS;

EID: 33644811496     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.04051.x     Document Type: Article

References (51)

1. Valle J, Kekki M, Sipponen P et al. Long-term course of a 32 year follow-up study. Scand. J. Gastroenterol. 1996 31 : 546 50.
2. Sirula M, Lehtola J, Ihamaki T. Atrophic gastritis and ist sequelae. Results of 19-23 years' follow-up examinations. Scand. J. Gastroenterol. 1974 9 : 441 6.
3. Walter IR, Strickland RG, Ungar B, Mackay IR. Simple atrophic gastritis and gastric carcinoma. Gut 1971 12 : 906 11.
4. Sipponen P, Kekki M, Haapakoski J et al. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int. J. Cancer 1985 35 : 173 7.
5. Rugge M, Cassaro M, Di Mario F et al. for the Interdisciplinary Group on Gastric Epithelial Dysplasia (IGGED). The long term outcome of gastric non-invasive neoplasia. Gut 2003 52 : 1111 16.
6. Niemelä S, Karttunen T, Kerola T. Helicobacter pylori-associated gastritis. Evolution of histologic changes over 10 years. Scand. J. Gastroenterol. 1995 30 : 542 9.
7. Varis O, Valle J, Sirula M. Is Helicobacter pylori involved in the pathogenesis of the gastritis characteristic of pernicious anemia? Comparison between pernicious anemia relatives and duodenal ulcer relatives. Scand. J. Gastroenrol. 1993 28 : 705 8.
8. Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM et al. Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand. J. Gastroenterol. Suppl. 1997 223 : 28 34.
9. Asante M, Mendall AM, Ballam L et al. Relationship between Helicobacter pylori, gastric parietal cell antibodies and heat shock proteins. Eur. J. Gastroenterol. Hepatol. 1999 11 : 1365 70.
10. Valle J, Seppälä K, Sipponen P, Kosunen T. Disappearence of gastritis after eradication of Helicobacter pylori. A morphometric study. Scand. J. Gastroenterol. 1991 26 : 1057 65.
11. Rauws EA, Langenberg W, Houthoff HJ et al. Campylobacter-pyloridis- associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988 94 : 33 40.
12. Sipponen P, Seppälä K. Gastritis-atrophic gastritis-intestinal metaplasia-cancer of the stomach: is this sequence reversibile? Russ. J. Gastroenterol. Hepatol. Coloproctol. 1999 2 : 30 35.
13. Tucci A, Poli L, Tosetti C et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am. J. Gastroenterol. 1998 93 : 1425 31.
14. Uemura N, Mukai T, Okamoto S et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol. Biomarkers Prev. 1997 6 : 639 42.
15. van der Hulst RW, van der Ende A, Dekker FW et al. Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study. Gastroenterology 1997 113 : 25 30.
16. El-Omar EM, Oien K, El-Nujumi A et al. Helicobacter pylori infection and chronic gastritis acid hyposecretion. Gastroenterology 1997 113 : 15 24.
17. Rugge M, Correa P, Dixon MF et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment. Pharmacol. Ther. 2002 16 : 1249 59.
18. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter IJ. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982 83 : 204 9.
19. Varis K, Sipponen P, Laxén F et al. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Scand. J. Gastroenterol. 2000 35 : 950 56.
20. Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The Updated Sydney System. Am. J. Surg. Pathol. 1996 20 : 1161 81.
21. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 2001 345 : 784 9.
22. Kokkola A, Sipponen P, Rautelin H et al. The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment. Pharmacol. Ther. 2002 16 : 515 20.
23. Kokkola A, Rautelin H, Puolakkainen P et al. Positive result by serology indicates active Helicobacter pylori infection in patients with atrophic gastritis. J. Clin. Microb. 1998 36 : 1808 10.
24. Karnes WE Jr, Samloff IM, Sirula M et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991 101 : 167 74.
25. Yamada T, Miwa H, Fujino T et al. Improvement of gastric atrophy after Helicobacter pylori eradication therapy. J. Clin. Gastroenterol. 2003 36 : 405 10.
26. Sung JJ, Lin SR, Ching JY et al. Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000 119 : 7 14.
27. Hojo M, Miwa H, Ohkusa T, Ohkura R, Kurusawa A, Sato N. Alteration of histological gastritis after cure of Helicobacter pylori. Aliment. Pharmacol. Ther. 2002 16 : 1923 32.
28. Zerbib F, Lenk C, Sawan B et al. Long term effects of Helicobacter pylori eradication on gastric antral mucosa in duodenal ulcer patients. Eur. J. Gastroenterol. Hepatol. 2000 12 : 719 25.
29. Satoh K, Kimura K, Takimoto T, Kihira K. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori. Helicobacter 1998 3 : 236 40.
30. Furuta T, Baba M, Takashima H et al. Effect of Helicobacter pylori infection on gastric juice pH. Scand. J. Gastroenterol. 1998 33 : 357 63.
31. Kyzekova J, Mour J. The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. Hepatogastroenterology 1999 46 : 209 22.
32. Ohkusa T, Fujiki K, Takashimizu I et al. Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated. Ann. Intern. Med. 2001 134 : 380 86.
33. Tepes B, Kavcic B, Zaletel LK et al. Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication. J. Pathol. 1999 188 : 24 9.
34. Rollan A, Giancaspero R, Fuster F et al. The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country. Am. J. Gastroenterol. 2000 95 : 50 56.
35. Maconi G, Lazzaroni M, Sangaletti O, Bargiggia S, Vago L, Bianchi Porro G. Effect of Helicobacter pylori eradication on gasatric histology, serum gastrin and pepsinogen I levels and gastric emptying in patients with gastric ulcer. Am. J. Gastroenterol. 1997 92 : 1844 8.
36. Annibale B, Marignai M, Azzoni C et al. Atrophic body gastritis: distinct features associated with Helicobacter pylori infection. Helicobacter 1997 2 : 57 64.
37. Witteman EM, Mravunac M, Becx MJCM et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J. Clin. Pathol. 1995 48 : 250 56.
38. Di Napoli A, Petrino R, Boero M, Bellis D, Chiandussi L. Quantitative assessment of histological changes in chronic gastritis after eradication of Helicobacter pylori. J. Clin. Pathol. 1992 45 : 796 8.
39. Haruma K, Mihara M, Okamoto E et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus-evaluation of 24-h pH monitoring. Aliment. Pharmacol. Ther. 1999 13 : 155 62.
40. El-Omar EM, Oien K, Murray LS et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000 118 : 22 30.
41. Trespi E, Broglia F, Villani L, Luinetti O, Fiocca R, Solcia E. Distinct profiles of gastritis in dyspepsia subgroups. Scand. J. Gastroenterol. 1994 29 : 884 8.
42. Forbes GM, Warren JR, Glaser ME, Gullen DJ, Marshall BJ, Collins BJ. Long-term follow-up of gastric histology after Helicobacter pylori eradication. J. Gastroenterol. Hepatol. 1996 11 : 670 73.
43. Ciok J, Dzieniszewski J, Lucer C. Helicobacter pylori eradication and antral intestinal metaplasia-two years follow-up study. J. Physiol. Pharmacol. 1997 48 (Suppl. 4 115 22.
44. Annibale B, Di Giulio E, Caruana P et al. The long-term effects of cure of Helicobacter pylori infection on patients with atrophic body gastritis. Aliment. Pharmacol. Ther. 2002 16 : 1723 31.
45. Sanduleanu S, Bruïne ADE, Biemond I et al. Ratio between serum IL-8 and pepsinogen A/C: a marker for atrophic body gastritis. Eur. J. Clin. Invest. 2003 33 : 147 54.
46. Väänänen H, Vauhkonen M, Helske T et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur. J. Gastroenterol. Hepatol. 2003 15 : 885 91.
47. Miki K, Moita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am. J. Gastroenterol. 2003 98 : 735 9.
48. Kuipers Ernst J. In through the out door: serology for atrophic gastritis. Eur. J. Gastroenterol. Hepatol. 2003 15 : 877 9.
49. Kamada T, Haruma K, Hata J et al. The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment. Pharmacol. Ther. 2003 18 : 245 52.
50. Savarino V, Mela SG, Zentilin P et al. Effect of Helicobacter pylori eradication on 24-hour gastric pH and duodenal gastric metaplasia. Dig. Dis. Sci. 2000 45 : 1315 21.
51. Ilijima K, Ohara S, Sekine H et al. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000 46 : 20 6.